GELESIS HOLDINGS, IN

GLS
End-of-day quote Nyse - 06:00 2022-12-01 pm EST
0.4800 USD +39.29%
Business Summary
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Other Pharmaceuticals
Gelesis Holdings, Inc., formerly Capstar Special Purpose Acquisition Corp., is a commercial stage biotherapeutics company built for consumer engagement. The Company focuses on advancing superabsorbent hydrogel therapeutics for chronic gastrointestinal (GI) diseases including excess weight, type two diabetes, Nonalcoholic Fatty Liver Disease (NAFLD)/ Nonalcoholic Steatohepatitis (NASH), functional constipation (FC), and inflammatory bowel disease. Its product, Plenity, is an orally administered capsule. Plenity is available by prescription via a telehealth consultation with a physician trained in weight management support, with free, unlimited follow-up visits as needed. Consumers can visit myplenity.com for online consultations. Its other pipeline candidate includes GS200 for weight loss in prediabetes and type two diabetes. It is also developing GS300 for the treatment of NAFLD and NASH, and GS500 for the treatment of FC.

Number of employees : 113 people.
Managers
Name Title
Yishai Zohar President, Chief Executive Officer & Director
Elliot Maltz Treasurer, Chief Financial & Accounting Officer
Harry L. Leider Chief Medical Officer
Elaine Chiquette Chief Scientific Officer
David Pass Chief Operating & Commercial Officer
Clayton Christopher Independent Director
Dominic Anthony Charles Perks Independent Director
Alison K. Bauerlein Independent Director
Paul R. Fonteyne Independent Director
Raju S. Kucherlapati Independent Director
Shareholders
Name Equities %
Puretech Health LLC 16,727,582 22.9%
HPSO SPV Ltd. 12,181,993 16.7%
SSD2 LLC 12,056,626 16.5%
China Medical System Holdings Limited 4,501,770 6.17%
Pacific Investment Management Co. LLC 3,165,411 4.34%
The Vanguard Group, Inc. 2,915,964 4.00%
Vitruvian Partners LLP 1,876,106 2.57%
Yishai Zohar 1,426,014 1.95%
Aristeia Capital LLC 1,412,642 1.94%
Periscope Capital, Inc. 1,400,000 1.92%
Sector Other Pharmaceuticals
1st jan.Capi. (M$)
GELESIS HOLDINGS, INC.-95.18%35
JOHNSON & JOHNSON4.57%467 679
ELI LILLY AND COMPANY34.07%356 089
ABBVIE INC.20.87%289 331
NOVO NORDISK A/S22.04%285 887
PFIZER, INC.-13.50%285 774
MERCK & CO., INC.43.58%278 995
ROCHE HOLDING AG-18.69%270 669
ASTRAZENECA PLC28.81%212 164
NOVARTIS AG4.81%192 650
BRISTOL-MYERS SQUIBB COMPANY29.72%180 080
AMGEN INC.26.91%152 342
SANOFI-3.17%112 783
GILEAD SCIENCES, INC.22.61%111 665
GSK PLC-13.36%70 368
DAIICHI SANKYO CO., LTD.50.60%62 399
BAYER AG16.68%56 492
TAKEDA PHARMACEUTICAL COMPANY LIMITED26.46%45 571
CHUGAI PHARMACEUTICAL CO., LTD-4.42%43 395
JIANGSU HENGRUI MEDICINE CO., LTD.-20.13%36 798
ASTELLAS PHARMA INC.11.44%28 074
Brand Portfolio
More brands of Gelesis Holdings, Inc.